Can a smarter pacemaker save your heart?

NCT ID NCT05214365

Recruiting now Prevention Sponsor: Hospital Clinic of Barcelona Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a newer pacemaker method (conduction system pacing) can better prevent heart muscle weakening compared to the standard method. Researchers will enroll 200 adults who need a pacemaker for a slow heart rhythm. The goal is to see which approach reduces the risk of heart failure and other complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pacemaker implantation (conventional vs. conduction system pacing)
What this could lead to: If successful, this could show that a specific pacing method reduces the risk of pacemaker-induced heart damage, leading to better long-term outcomes for patients.
What could go wrong: This is a relatively small, early-stage study. The results may not apply to all patients, and the benefits of one pacing method over the other may be small or not clinically significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIOVENTRICULAR BLOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrioventricular block

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONDUCTION SYSTEM PACING CONVENTIONAL VENTRICULAR PACING

Contacts and locations

Locations

Hospital Clinic of Barcelona
RECRUITING

Barcelona, 08036, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.